Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Luminal B”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableLooking for participantsNCT04133077
What this trial is testing

Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer

Who this might be right for
Breast Cancer Female
Centre Jean Perrin 85
Testing effectiveness (Phase 2)Study completedNCT03248427
What this trial is testing

Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 106
Not applicableStudy completedNCT04118062
What this trial is testing

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Who this might be right for
Metastatic Uveal MelanomaTriple Negative Breast CancerLuminal B Breast Cancer+1 more
Institut Curie 128
Testing effectiveness (Phase 2)Study completedNCT01779479
What this trial is testing

Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 333
Large-scale testing (Phase 3)Study completedNCT01314833
What this trial is testing

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Who this might be right for
Primary Breast Cancer
Fudan University 1,570
Testing effectiveness (Phase 2)Active Not RecruitingNCT03875573
What this trial is testing

Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:

Who this might be right for
Luminal B
Jules Bordet Institute 147
Testing effectiveness (Phase 2)Study completedNCT04659551
What this trial is testing

Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients

Who this might be right for
Breast Cancer
Istituto Oncologico Veneto IRCCS 43
Large-scale testing (Phase 3)WithdrawnNCT06585969
What this trial is testing

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerER-positive Breast CancerLuminal B+2 more
Danish Breast Cancer Cooperative Group
Not applicableEnded earlyNCT01984866
What this trial is testing

CPR Prediction After Neoadjuvant Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.

Who this might be right for
Triple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients
Hospital General Universitario Gregorio Marañon 13
Testing effectiveness (Phase 2)Study completedNCT05163106
What this trial is testing

Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole

Who this might be right for
Breast CancerHER2-negative Breast CancerER-positive Breast Cancer+3 more
University Hospital, Akershus 85
Very early researchStudy completedNCT02802748
What this trial is testing

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 60
Not applicableStudy completedNCT03860740
What this trial is testing

Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients

Who this might be right for
Breast CancerLuminal B
Spanish Breast Cancer Research Group 12
Testing effectiveness (Phase 2)Ended earlyNCT02806258
What this trial is testing

Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone

Who this might be right for
Radiation Therapy, Breast Cancer, Sequential Partial Breast IrradiationIntermediate and High-risk Luminal and Triple Negative Breast Cancer
University Hospital, Grenoble 362
Not applicableLooking for participantsNCT05673304
What this trial is testing

Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer

Who this might be right for
Breast CancerRadiotherapy
IRCCS Azienda Ospedaliero-Universitaria di Bologna 30
Testing effectiveness (Phase 2)Study completedNCT01669252
What this trial is testing

Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 163
Testing effectiveness (Phase 2)Looking for participantsNCT03815890
What this trial is testing

Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02603679
What this trial is testing

Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases

Who this might be right for
Early-Stage Breast CarcinomaEstrogen Receptor Positive Tumor
Thomas Hatschek 181
Testing effectiveness (Phase 2)WithdrawnNCT03841747
What this trial is testing

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Queen Mary University of London
Not applicableUnknownNCT01779531
What this trial is testing

Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Guangdong Academy of Medical Sciences 640
Testing effectiveness (Phase 2)UnknownNCT03712956
What this trial is testing

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Who this might be right for
Breast Cancer
European Institute of Oncology 63
Load More Results